Miia Kivipelto, MD, PhD, describes the value of an early diagnosis of Alzheimer’s disease alongside the disclosure of diagnosis and clinical management options for a patient who has been diagnosed with Alzheimer’s disease in the early stages. She also provides preliminary results from non-pharmacological intervention studies and describes the potential role of these interventions in the patient case study.
Disclosure: All panelists received honoraria from Biogen for participation in this symposium.
Disclaimer: All of the information discussed today is for informational purposes only; does not constitute medical advice; and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment.